眼眶组织T细胞与B细胞浸润与Graves眼病临床特征的相关性
一项在三级转诊中心开展的队列研究纳入20例接受眼眶减压术的Graves眼病患者,采用组织学与免疫组化评估眼眶淋巴细胞浸润及其表型,发现淋巴细胞总数及CD3阳性T细胞、CD20阳性B细胞数量均与临床活动度评分(CAS)相关,校正吸烟与GO病程后相关性仍存在。
要点
- 20例GO患者中9例(45%)眼眶组织淋巴细胞数超过既定 cutoff 值300个/组织样本。
- 浸润淋巴细胞为T细胞(CD3阳性)与B细胞(CD20阳性)混合,提示成熟多克隆自身免疫反应。
- 淋巴细胞总数及CD3阳性、CD20阳性亚群数量均与CAS相关,校正吸烟和GO病程后仍显著。
核心结论
- 眼眶组织浸润的T细胞与B淋巴细胞与Graves眼病活动度存在相关性,可能有助于理解GO免疫特征与临床表现的关联。
研究设计与样本
- 队列研究,在三级转诊中心纳入20例连续接受眼眶减压术的Graves眼病患者,研究时间为2017年1月1日至5月31日。
- 暴露评估包括眼眶组织组织学与免疫组化检测以及眼科评估。
- 主要结局指标为CAS与眼眶淋巴细胞总数及主要淋巴细胞亚群的关联。
主要发现
- 患者共20例,其中男8例、女12例,均为白种人,平均(SD)年龄46(13)岁。
- 以每组织样本300个淋巴细胞为既定 cutoff 值,20例中9例(45%)眼眶组织淋巴细胞数高于该值,常形成 distinct foci。
- 淋巴细胞为T细胞(CD3阳性)与B细胞(CD20阳性)混合,提示成熟多克隆自身免疫反应。
- 简单线性回归中,淋巴细胞总数与CAS相关(R=0.63;95%CI 0.27-0.84;P=.003),CD3阳性亚群与CAS相关(R=0.59;95%CI 0.20-0.82;P=.006),CD20阳性亚群与CAS相关(R=0.65;95%CI 0.30-0.85;P=.002)。
- 多线性回归校正吸烟与GO病程后,淋巴细胞总数仍与CAS相关(R=0.58;95%CI 0.18-0.82;P=.01),CD3阳性仍相关(R=0.58;95%CI 0.17-0.82;P=.01),CD20阳性仍相关(R=0.59;95%CI 0.19-0.83;P=.01)。
关键数值与推荐
- 眼眶淋巴细胞 cutoff 值为每组织样本300个淋巴细胞。
- 淋巴细胞总数与CAS的简单线性回归:R=0.63;95%CI 0.27-0.84;P=.003。
- CD3阳性T细胞与CAS的简单线性回归:R=0.59;95%CI 0.20-0.82;P=.006。
- CD20阳性B细胞与CAS的简单线性回归:R=0.65;95%CI 0.30-0.85;P=.002。
- 多线性回归校正吸烟与GO病程后,淋巴细胞总数R=0.58(95%CI 0.18-0.82;P=.01),CD3阳性R=0.58(95%CI 0.17-0.82;P=.01),CD20阳性R=0.59(95%CI 0.19-0.83;P=.01)。
临床怎么用
- 原文未报告临床实践建议。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Graves orbitopathy (GO) responds to immunosuppressive treatments when clinically active but poorly when inactive. In other autoimmune diseases, response has been ascribed to a reduction in lymphocytes infiltrating the target organ. It is not known whether active vs inactive GO differs in this regard, which would help in understanding the link between GO immunologic features and clinical behavior. OBJECTIVE: To investigate the association between orbital lymphocytic infiltrate and GO clinical features. DESIGN, SETTING, AND PARTICIPANTS: A cohort study aimed at assessing the extent and immunohistochemical phenotype of orbital lymphocytes and associating it with the ophthalmologic features of GO, especially its clinical activity score (CAS), was conducted at a tertiary referral center. Twenty consecutive patients with GO who underwent orbital decompression were included. The study was conducted from January 1 to May 31, 2017. EXPOSURES: Orbital tissue histology and immunohistochemistry testing as well as ophthalmologic evaluation. MAIN OUTCOMES AND MEASURES: Association between CAS and orbital lymphocytes, analyzed as total number of lymphocytes and main lymphoid subsets. RESULTS: The patient population included 8 men and 12 women, all of white race, with a mean (SD) age of 46 (13) years. With an established cutoff value of 300 lymphoid cells per tissue sample, lymphocytes above this value were found in orbital tissues of 9 of 20 patients (45%), often organized into distinct foci. The lymphocytes comprised a mixture of T (CD3-positive) and B (CD20-positive) cells, suggesting a mature, polyclonal autoimmune response. In a simple linear regression model, the total number of lymphocytes, as well as the number of CD3- and CD20-positive subsets, correlated with CAS (R = 0.63; 95% CI, 0.27-0.84; P = .003; R = 0.59; 95% CI, 0.20-0.82; P = .006; and R = 0.65; 95% CI, 0.30-0.85; P = .002, respectively). In a multiple linear regression model, lymphocytes maintained their effect on CAS when adjusted for 2 additional variables that were correlated with CAS-smoking and GO duration-highlighting even more the important role of orbital lymphocytes in affecting CAS (total number: R = 0.58; 95% CI, 0.18-0.82; P = .01; CD3-positive: R = 0.58; 95% CI, 0.17-0.82; P = .01; and CD20-positive: R = 0.59; 95% CI, 0.19-0.83; P = .01). CONCLUSIONS AND RELEVANCE: This study shows a correlation between T and B lymphocytes infiltrating orbital tissues and the activity of GO, possibly enhancing our understanding of the association between GO immunologic features and clinical expression.
引用
- Rotondo Dottore G, Torregrossa L, Caturegli P, et al. Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy. JAMA Ophthalmol. 2018. PMID: 29710102. doi:10.1001/jamaophthalmol.2018.0806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。